2. Introduction: Who am I?
| 2
Maike Stenull
• Vice President and Global Head
Strategy & Operations
Johnson & Johnson External Innovation
• 29 years with J&J
• All 3 sectors of J&J (Pharma, Consumer,
Medical Device)
• Germany, U.K., USA
• Finance, Strategy, Portfolio
• MBA, Six Sigma Black Belt
3. More Than 130 Years:
Creating Value
Through Innovation
| 3
3
Business
Segments
175countries
Products in
more than
130,000
Over
employees worldwide
Invested in R&D
in 2019
$11.4B
4. Global Brands: Broad Reach And Scale
| 4
PHARMACEUTICALS
MEDICAL DEVICES
CONSUMER PRODUCTS
5. Our Goal: Transforming Lives Through Innovation
VALUE FOR SOCIETY
Years of Life Quality of Life Overall Well-being
| 5
6. “Innovation at Johnson &
Johnson is about creating
strong networks of people
who can combine resources,
ideas and technologies in a
new way.”
Paul Stoffels, M.D.
Vice Chair of the Executive Committee
and Chief Scientific Officer
Johnson & Johnson
Innovation:
It’s About The People
7. Feeding the “Beast”:
A Monumental Task
| 7
5%
Sales
Growth
~$4B=
Consumer Products Medical Devices Pharmaceuticals
8. Innovation Level Needed to Succeed:
Dramatically Increased Expectations
LevelofInnovation
Time
Higher threshold
Speed
Value
Market
expectations
Me too
late
Differentiated
product
| 8
12. Co-Dependent Ecosystem:
We Need Each Other
INDUSTRY NEEDS ENTREPRENEURS NEED
VS
INNOVATION
AGILITY
COST
SAVINGS
INFRASTRUCTURE
CAPITAL EXPERTISE
| 12
13. Tailor-Made Solutions for Entrepreneurs:
Comprehensive Global Offerings
INNOVATION CENTERS
Early Stage Acceleration
•4 Innovation Centers
–London
–Shanghai
–San Francisco
–Boston
•400+ deals done over
past 6 years
JJDC
Strategic Investing
•Oldest Corporate
Venture Arm (45+
years)
BUSINESS
DEVELOPMENT
Late Stage Deals
•Licensing, M&A and
Alliance Management
•40+ years
JLABS
Life Science Incubators
•13 locations across the
globe
| 13
14. Johnson & Johnson Innovation Network:
World, we Got You Covered!
EMEA
Innovation Center
London, U.K.
FutuRx
Israel, Weizmann
Science Park
East NA
Innovation Center
Boston, MA
JPOD @ Boston
JLABS Boston
(JLABS @ LabCentral)
West NA
Innovation Center
South San Francisco, CA
JLABS Toronto Canada
(JLABS @ Toronto)
JLABS Bay Area
(JLABS @ QB3)
JLABS San Diego, La Jolla
(JLABS @ San Diego)
JLABS Houston
Texas Medical Center
(JLABS @ TMC)
Japan
Singapore
JLABS South
San Francisco
(JLABS @ SSF)
Innovation Center (IC) IC Offices JLABS Partnering
APAC
Innovation Center
Shanghai, China
JLABS New York
(JLABS @ NYC)
Med Devices
JLABS Beerse, Belgium
(JLABS @ BE)
JLABS Shanghai, China
(JLABS @ Shanghai)
JLABS Lowell
(JLABS @ M2D2)
CDI @ TMC
JJIPO @ Seoul Bio Hub
Korea
JJIPO @ QUT
Queensland
JJIPO @ Monash
Melbourne
Sydney
Seoul
JPOD @ Philadelphia
Hong Kong
JLABS @ Washington, D.C.
| 14
15. Making it Easy For Innovation to Find us:
Quick Fire Challenges & Quick Pitches
| 15
This crowdsourcing platform seeks to
empower and enable groundbreaking
science and health solutions by encouraging
students, entrepreneurs, researchers, and
start-up companies to apply.
44
QFCs
$7.5+
in prizes
82
awardees worldwide
J&J Innovation launched:
16. Connecting External & Internal Innovation:
Leveraging The Best Ideas to Eliminate Diseases
| 16
Lung Cancer
Cross Sector Initiative to
Prevent, Intercept & Cure
Lung Cancer
World Without Disease
Immorbidity: Aging in Total
Freedom From Disease or
Sickness
17. Sir William Preece
Chief Engineer, British
Post Office. 1878
The Americans have
need of the telephone,
but we do not. We have
plenty of messenger
boys.
18. Thomas J. Watson
CEO, IBM. 1943
I think there is a
world market for
computers.
maybe five
21. In Summary
| 21
• Transformational innovation is the
lifeblood of our business
• Agnostic of where innovation originates
• Plugged into the innovation grid
• Making it easy for the red ping pong
balls to find us
• The world is our lab
Editor's Notes
Johnson & Johnson is one of the largest and most diversified health care companies in the world. And we have been working for more than 130 years to create value through innovation for patients, our customers, our employees, and our shareholders.
We operate:
Across three business segments – Consumer, Medical Device, and Pharmaceuticals
In more than 175 countries
Leveraging more than 250 operating companies
And we have more than 130,000 employees worldwide
You may readily associate our consumer brands with J&J, products like those I just mentioned. But– J&J is also very much focused on Medical Devices and Pharma and you may recognize some of these brands as well. These are life changing, life improving, life saving brands. All powered by Innovation. And used by 1 Billion people a day.
Why do we do this? Because, if we do this right, we can innovate to extend years of life, improve quality of life and increase overall well being.
This quote from our Chief Scientific Officer M.D. is at the core of our J&J Innovation model.
Innovation is occurring all over the world, but how do we harness it? How do we work with the entrepreneurs and academics to help take their products and technologies from concept to commercialization? How do we create the networks to stimulate innovation?
Johnson & Johnson Innovation was founded to provide a solution to these problems.
broadest based hc company in the world
Most know baby shampoo and BandAids
To continue serving the needs of our customers, we have a relentless focus on innovation. And not just incremental innovation; transformational innovation. Because the medical challenges we face are more complex than ever.
The threshold for innovation is continuing to rise, which has an impact on the growing cost of research and development. The global economic climate poses challenges and we face higher regulatory hurdles and demands from payers.
Everyone in this room is familiar with the phenomenon depicted here. If you start the level of innovation too low, by the time your solution reaches the market is out it doesn’t necessarily meet market expectations, which continue to advance over time.
Whereas if you start at a very high level of innovation - which can be more risky - all the time/effort you put in will reap a truly differentiated product with high impact and high value.
This is where we want to be (speed line).
In summary, this unconventional slide expresses best what J&J Innovation is looking for. At least for me.
The slide depicts the Olympic Gold Medal Winners in High Jump over time. The athletes started out with the so called “Scissors” technique, and it was improved over time to get to greater heights. But then, a revolutionary new technique was invented that was called the “Western Roll”, which substantially increased the height the athletes were able to scale. Then came the “Straddle”, where you would jump over the bar face first. And still today, the high jumpers do the so called “Fosbury Flop”. It was introduced by Dick Fosbury, who won the 1968 Olympics with that style. What will be next?
While incremental innovation has its place, improving current practice that leads to better results, the transformational innovation is a game changer. J&J is looking for the next Fosbury Flop.
This quote from our Chief Scientific Officer M.D. is at the core of our J&J Innovation model.
Innovation is occurring all over the world, but how do we harness it? How do we work with the entrepreneurs and academics to help take their products and technologies from concept to commercialization? How do we create the networks to stimulate innovation?
Johnson & Johnson Innovation was founded to provide a solution to these problems.
We focused on the unique needs of both sides of the partnering equation
Industry needs: innovation, small nimble teams, cost savings
Entrepreneurs need: infrastructure, capital, expertise
Well, we created locations around the world to bring these two sides together in the most efficient way possible. Instead of coming to us in a central location that’s convenient for us, we embedded ourselves in hotspots of innovation. And then leveraging J&J Innovation’s many resources, including our Innovation Centers, JLABS, JJDC and Janssen Business Development, we identify the right partnerships and the right deal structures, to allow innovators to do what they do best, while working with us to improve the lives of people and patients. It’s like personalized medicine, but for innovation and collaboration.
We have been working for more than 125 years – creating value through innovation for patients, our customers, our employees, and our shareholders.
We operate:
Across three business segments – Consumer, Medical Device, and Pharmaceuticals
In more than 175 countries
We focused on the unique needs of both sides of the partnering equation
Industry needs: innovation, small nimble teams, cost savings
Entrepreneurs need: infrastructure, capital, expertise
Creative commons with attibution
http://www.offset.com/mysets/45946627
We focused on the unique needs of both sides of the partnering equation
Industry needs: innovation, small nimble teams, cost savings
Entrepreneurs need: infrastructure, capital, expertise